Registered number
07410603
Battersea Pharmacy Limited
Filleted Unaudited Accounts
31 March 2024
Battersea Pharmacy Limited
Registered number: 07410603
Balance Sheet
as at 31 March 2024
Notes 2024 2023
£ £
Fixed assets
Intangible assets 3 184,997 285,848
Tangible assets 4 466 621
Investments 5 - 10,000
185,463 296,469
Current assets
Debtors 6 76,041 39,342
Cash at bank and in hand - -
76,041 39,342
Creditors: amounts falling due within one year 7 (216) (5,278)
Net current assets 75,825 34,064
Total assets less current liabilities 261,288 330,533
Net assets 261,288 330,533
Capital and reserves
Called up share capital 100 100
Profit and loss account 261,188 330,433
Shareholder's funds 261,288 330,533
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mr R Rohilla
Director
Approved by the board on 20 November 2024
Battersea Pharmacy Limited
Notes to the Accounts
for the year ended 31 March 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). The company is a small parent company. These accounts show the results of the individual company.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery 25% reducing balance
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Going concern
The company has subsequently ceased trading and will be wound up in the next year.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 3 3
3 Intangible fixed assets £
Goodwill:
Cost
At 1 April 2023 585,295
At 31 March 2024 585,295
Amortisation
At 1 April 2023 299,447
Provided during the year 100,851
At 31 March 2024 400,298
Net book value
At 31 March 2024 184,997
At 31 March 2023 285,848
Goodwill is being written off in equal annual instalments over its estimated economic life of 20 years. Following the decision to cease trade the goodwill purchased initially for the company has been written off.
4 Tangible fixed assets
Plant and machinery Total
£ £
Cost
At 1 April 2023 21,483 21,483
At 31 March 2024 21,483 21,483
Depreciation
At 1 April 2023 20,862 20,862
Charge for the year 155 155
At 31 March 2024 21,017 21,017
Net book value
At 31 March 2024 466 466
At 31 March 2023 621 621
5 Investments
Investments in
subsidiary Other
undertakings investments Total
£ £ £
Cost
At 1 April 2023 10,000 - 10,000
Disposals (10,000) - (10,000)
At 31 March 2024 - - -
Historical cost
At 1 April 2023 10,000 -
At 31 March 2024 - -
6 Debtors 2024 2023
£ £
Amounts owed by group undertakings and undertakings in which the company has a participating interest 74,789 37,918
Other debtors 1,252 1,424
76,041 39,342
7 Creditors: amounts falling due within one year 2024 2023
£ £
Director's loan account - 3,278
Taxation and social security costs - 1,759
Other creditors 216 241
216 5,278
8 Related party transactions
The company received income of £55,000 (2023 £55,000) from G B Patel & Sons Limited, a company of which the director is also a director and shareholder.
9 Controlling party
The company is controlled by Mr R Rohilla, the director, who owns all the shares of the company.
10 Other information
Battersea Pharmacy Limited is a private company limited by shares and incorporated in England. Its registered office is:
27 Northcote Road
London
SW11 1NJ
Battersea Pharmacy Limited 07410603 false 2023-04-01 2024-03-31 2024-03-31 VT Final Accounts July 2024 Mr R Rohilla No description of principal activity 07410603 2022-04-01 2023-03-31 07410603 core:WithinOneYear 2023-03-31 07410603 core:ShareCapital 2023-03-31 07410603 core:RetainedEarningsAccumulatedLosses 2023-03-31 07410603 2023-04-01 2024-03-31 07410603 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 07410603 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 07410603 bus:Director40 2023-04-01 2024-03-31 07410603 1 2023-04-01 2024-03-31 07410603 2 2023-04-01 2024-03-31 07410603 core:Goodwill 2023-04-01 2024-03-31 07410603 core:PlantMachinery 2023-04-01 2024-03-31 07410603 countries:England 2023-04-01 2024-03-31 07410603 bus:FRS102 2023-04-01 2024-03-31 07410603 bus:FilletedAccounts 2023-04-01 2024-03-31 07410603 2024-03-31 07410603 core:WithinOneYear 2024-03-31 07410603 core:ShareCapital 2024-03-31 07410603 core:RetainedEarningsAccumulatedLosses 2024-03-31 07410603 core:Goodwill 2024-03-31 07410603 core:PlantMachinery 2024-03-31 07410603 core:DisposalsRepaymentsInvestments 2024-03-31 07410603 2023-03-31 07410603 core:Goodwill 2023-03-31 07410603 core:PlantMachinery 2023-03-31 iso4217:GBP xbrli:pure